4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-051790
Chief Executive Officer sold 7,800 shares at an average $39.81 ($310,479)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-09-18 | Sale | −3,900 | $39.62 | $154,518 | 62,578 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-09-19 | Sale | −3,900 | $39.99 | $155,961 | 58,678 | I: show line 2 in the form |
| Open-market sales · 7,800 sh · avg $39.81 · $310,479 | |||||||
Loading xslF345X03/doc4.xml…